|The Life Cycle Of Pharmaceuticals: Adding Value At Each Stage [On-Demand]
Rajeev Sharma,Torkin Manes LLP & Matthew Castellarin, Bayer Inc.
The life cycle of a pharmaceutical product from invention to the end of the patent term raises a myriad of complex multi-disciplinary issues. Even if the drug eventually obtains regulatory approval from Health Canada, the numerous premarketing hurdles take years, significant investment and requires the successful synchronization of many moving parts often in a global organization. This seminar attempts to demystify and distil all of the moving parts into an easily understandable session for both legal and non-legal professionals. The one-day seminar will bring together different subject matter experts to provide targeted sessions in order to help professionals working in life sciences get a complete picture of the process so that they can add strategic value to their clients each step of the way. The panels will focus on each critical stage of the life cycle and provide an overview of the risks and opportunities. In addition to seasoned in-house legal executives, outside counsel and regulators the panels will include executives from medical and scientific affairs, regulatory affairs, public affairs, reimbursement, pricing, market access, drug safety and sales/marketing. more ...